Aug
19
2020
Unity Biotechnology Fails Phase II Trial of Localized Senolytics for Knee Osteoarthritis
UNITY Biotechnology is the largest of the handful of biotech startups working on senolytics, therapies capable of selectively destroying a sizable fraction of the senescent cells that accumulate in old...